0341 GMT - Raffles Medical Group is likely to benefit from its strategic collaboration with Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Maybank Research's Eric Ong says, noting the recent signing of an agreement. The two entities agreed to establish a "dual circulation" medical resource service system, to advance a new model of collaborative development and promote Shanghai as an international medical tourism hub, the analyst says. Raffles Medical Group's international-standard service system will be integrated into China's domestic healthcare system, the analyst adds. The brokerage raises the stock's target price to S$1.13 from S$1.03, with an unchanged buy rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
April 23, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。